Advances in epigenetic modifications and cervical cancer research

Biochim Biophys Acta Rev Cancer. 2023 May;1878(3):188894. doi: 10.1016/j.bbcan.2023.188894. Epub 2023 Apr 1.

Abstract

Cervical cancer (CC) is an important public health problem for women, and perspectives and information regarding its prevention and treatment are quickly evolving. Human papilloma virus (HPV) has been recognized as a major contributor to CC development; however, HPV infection is not the only cause of CC. Epigenetics refers to changes in gene expression levels caused by non-gene sequence changes. Growing evidence suggests that the disruption of gene expression patterns which were governed by epigenetic modifications can result in cancer, autoimmune diseases, and various other maladies. This article mainly reviews the current research status of epigenetic modifications in CC based on four aspects, respectively DNA methylation, histone modification, noncoding RNA regulation and chromatin regulation, and we also discuss their functions and molecular mechanisms in the occurrence and progression of CC. This review provides new ideas for early screening, risk assessment, molecular targeted therapy and prognostic prediction of CC.

Keywords: DNA methylation; Epigenetic modification; Histone modification; Molecular marker; Noncoding RNA regulation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatin
  • DNA Methylation
  • Epigenesis, Genetic
  • Female
  • Humans
  • RNA, Untranslated / genetics
  • Uterine Cervical Neoplasms* / genetics

Substances

  • Chromatin
  • RNA, Untranslated